Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Accured Expenses: 2021-2024

Historic Change in Accured Expenses for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$230,000.

  • Biofrontera's Change in Accured Expenses fell 29.42% to $746,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 115.22%. This contributed to the annual value of -$230,000 for FY2024, which is 96.38% up from last year.
  • Per Biofrontera's latest filing, its Change in Accured Expenses stood at -$230,000 for FY2024, which was up 96.38% from -$6.4 million recorded in FY2023.
  • Over the past 5 years, Biofrontera's Change in Accured Expenses peaked at $12.5 million during FY2021, and registered a low of -$6.4 million during FY2023.
  • Over the past 3 years, Biofrontera's median Change in Accured Expenses value was -$3.6 million (recorded in 2022), while the average stood at -$3.4 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first slumped by 128.89% in 2022, then skyrocketed by 96.38% in 2024.
  • Over the past 4 years, Biofrontera's Change in Accured Expenses (Yearly) stood at $12.5 million in 2021, then plummeted by 128.89% to -$3.6 million in 2022, then crashed by 76.07% to -$6.4 million in 2023, then skyrocketed by 96.38% to -$230,000 in 2024.